IL18 and Alzheimer disease: We could unravel a functional switch of the LC by diminishing the classical antigen‐presenting and T cell interacting factors and the directed migratory activity, but promoting the release of IL‐18 and IL‐1β, both of which can drive T2 immunity indirectly and are associated with AD.